Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AZN.LN | ||||
| Company | Astrazeneca Plc | ||||
| Price Information | |||||
| Exchange | LSE | ||||
| Open | 15,022.000 | ||||
| High | 15,032.000 | ||||
| Low | 14,960.000 | ||||
| Latest | 14,990.000 | ||||
| Change | +2.000 | ||||
| % Change | +0.01% | ||||
| Volume | 11,330,012 | ||||
| 20-Day Average Volume | 3,841,138 | ||||
| Previous Close | 14,988.000 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 14,561.183 | ||||
| 20-Day Raw Stochastic | 76.06% | ||||
| 20-Day Relative Strength | 54.89 | ||||
| Weighted Alpha | +46.58 | ||||
| Today's Opinion | 88% Buy | ||||
| Previous Opinion | 88% Buy | ||||
| Last Month's Opinion | 64% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 04/07/26 | ||||
| Low | 14,922.000 on 04/13/26 | ||||
| High | 15,449.998 on 04/10/26 | ||||
| 1-Month | |||||
| %Chg | +4.16% since 03/13/26 | ||||
| Low | 13,478.000 on 03/23/26 | ||||
| High | 15,449.998 on 04/10/26 | ||||
| 3-Month | |||||
| %Chg | +4.41% since 01/14/26 | ||||
| Low | 13,268.000 on 01/20/26 | ||||
| High | 15,732.000 on 02/18/26 | ||||
| 6-Month | |||||
| %Chg | +17.59% since 10/14/25 | ||||
| Low | 12,240.000 on 11/04/25 | ||||
| High | 15,732.000 on 02/18/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 236,191,908 | ||||
| Shares Outstanding, K | 1,550,833 | ||||
| Annual Sales | 58,739,000,000 | ||||
| Annual Net Income | 10,225,000,000 | ||||
| Last Quarter Sales | 15,503,000,000 | ||||
| Last Quarter Net Income | 2,326,000,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | 1.49 on 02/10/26 | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | 1.595 on 02/19/26 | ||||
| Next Ex-Dividends Date | 02/19/26 | ||||
| Ratios | |||||
| Price/Earnings ttm | 31.27 | ||||